Generalsuche Home Home mobil Mobil Help Hilfe Sitemap Sitemap Kontakt Kontakt Impressum Impressum Datenschutz Datenschutz RSS Feed Feeds
News / Newsletter
Veranstaltungen / Events
Publikationen / E-Library
AMS Publikationen - Forschung
AMS Standing Committees
AMS Vision Rundschau
E-Library - Bibliograph. Suche
E-Library - Volltext Suche
Jobchancen Studium
Merkliste Merkliste News
Merkliste Merkliste Events
Merkliste Merkliste E-Library
Merkliste Merkliste Jobch. News
Merkliste Merkliste Methoden
Detailansicht E-LibraryKurztipp   
zurück zur Willkommenseite  
  Merkliste bearbeiten / via E-Mail sendenTitel merken  
VerfasserInnen / HerausgeberInnen
AutorIn 1:Wittkowski, Knut M.
Titel:The first three months of the COVID-19 epidemic: Epidemiological evidence for two separate strains of SARS-CoV-2 viruses spreading and implications for prevention strategies
Anmerkung:medRxiv preprint doi: / COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
Abstract:"(...) About one month after the COVID-19 epidemic peaked in Mainland China and SARS-CoV-2 migrated from China westward to Europe and then the U.S., the epidemiological data begin to provide important insights into the risks associated with the disease and the effectiveness of intervention strategies. Like other respiratory diseases, including the 2003 SARS epidemic, the virus remains only about two months in any given population, yet the peak incidence and the lethality can vary. The data suggest that at least two strains of the 2020 SARS-CoV-2 virus have evolved during its migration from Mainland China to Europe. South Korea, Iran, and Italy were hit by the more dangerous "SKII" variant. While the epidemic in China is about to end, and in Europe about to level off, the course of the epidemic in the younger US population is still increasing and the peak level will likely depend on which of the strains has entered the US first. The same models that help us to understand the epidemic also help us to choose prevention strategies. While containment merely prolongs the time the disease circulates until the proportion of immune people is high enough for "herd immunity", reducing disease severity, either by vaccination or by early treatment of complications, is the best strategy against a respiratory virus disease. (...)"
Download: hier klicken (PDF  1,00 MB)
URL: medrxiv